Sorrento Therapeutics Inc

+0.08 (+5.20%)
Mergers / Acquisitions

Scilex Holding Company, To Become Publicly Traded Through A Merger With Vickers Vantage Corp. I

Published: 03/17/2022 19:47 GMT
Sorrento Therapeutics Inc (SRNE) - Scilex Holding Company, a Majority-owned Subsidiary of Sorrento Therapeutics, Inc., to Become Publicly Traded Through a Merger With Vickers Vantage Corpivickers Vantage Corp I - Combined Company Expected to Have a Pro Forma Equity Value Post-money of Approximately $1.64 Billion.
Vickers Vantage Corp I - Combined Company's Common Stock is Expected to Be Listed on Nasdaq Under New Ticker Symbol "sclx".
Vickers Vantage Corp I - Up to $140 Million in Expected Gross Proceeds Before Expenses.
Vickers Vantage Corp I - in Connection With Deal Vcka's Sponsors Have Agreed to Cancel 40% of Their Private Warrants If Redemptions Exceed 75%.
Vickers Vantage Corp I - Scilex's Existing Equity Holders Will Roll 100% of Their Equity Into Combined Company.
Vickers Vantage Corp I - Estimated That Current Stockholders of Scilex Will Own Approximately 88% of Outstanding Shares of Combined Company.